Evidence map›Paper›PMID 37069218›Full record

ArticleScientific reports2023

An investigation into epidemiological situations of COVID-19 with fuzzy K-means and K-prototype clustering methods.

Ozge Pasin, Senem Gonenc

Abstract read
In one paragraph

Article in Scientific reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Observational
  3. Article
  4. Article
  5. Article
  6. Observational
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Ozge PasinBiostatistics Department, Faculty of Medicine, Bezmialem University, Fatih, Istanbul, Turkey. opasin@bezmialem.edu.tr.
Senem GonencStatistics Department, Faculty of Science, Ataturk University, Erzurum, Turkey.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The ten countries with the highest population during the pandemic were analyzed for clustering based on the quantitative numbers of COVID-19 and policy plans. The Fuzzy K-Means (FKM) and K-prototype algorithms were used for clustering, and various performance indices such as Partition Coefficient (PC), Partition Entropy (PE), Xie-Beni (XB), and Silhouette Fuzzy (SIL.F) were used for evaluating the clusters. The analysis included variables such as confirmed cases, tests, vaccines, school and workplace closures, event cancellations, gathering restrictions, transport closures, stay-at-home restrictions, international movement restrictions, testing policies, facial coverings, and vaccination policy statuses. PC, PE, XB, and SIL.F indices were used to analyze the performance indices of the clusters. The Elbow method was used to analyze the performance evaluations for the K-prototype. The K-prototype algorithm's performance evaluations were analyzed using the Elbow method, and the optimum number of clusters for both methods was found to be two. The first cluster included Brazil, Mexico, Nigeria, Bangladesh, US, Indonesia, Russia, and Pakistan, while the second cluster comprised India and China. The analysis also examined the relationship between population and confirmed tests and vaccines, and standardization was made for the country with the largest population for significant correlations. The results showed that the FKM method was superior to the K-prototype method in terms of clustering. In conclusion, it is crucial to accurately evaluate COVID-19 data for countries and develop appropriate policies. The clustering analysis using the FKM and K-prototype algorithms provides valuable insights into identifying groups of countries with similar COVID-19 data and policy plans.

Indexed as

COVID-19Fuzzy LogicAlgorithmsBangladeshCluster AnalysisHumans

Identifiers

PMID37069218
PMCPMC10108788

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.